世界の避妊薬・避妊具市場2021:メーカー別・地域別・種類別・用途別市場予測(~2026)

GlobalInfoResearchが発行した調査報告書(GIR21AR03783)
◆英語タイトル:Global Contraceptives Drugs and Devices Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
◆商品コード:GIR21AR03783
◆発行会社(リサーチ会社):GlobalInfoResearch
◆発行日:2021年4月
◆ページ数:106
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2~3日)
◆調査対象地域:グローバル
◆産業分野:医療機器・消耗品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥400,200見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥600,300見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥800,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

GlobalInfoResearch社の本調査レポートでは、避妊薬・避妊具の世界市場を広く調査・分析し、今後の市場展望をまとめております。避妊薬・避妊具の種類別市場規模(避妊薬(経口避妊薬、避妊注射剤、局所避妊薬)、避妊具(男性用避妊具、女性用避妊具))、用途別市場規模(女性用、男性用)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(企業概要、製品概要、販売量、価格、売上):Teva Pharmaceutical Industries Ltd、Church & Dwight Co. Inc、Reckitt Benckiser Plc、Pfizer, Inc、Bayer AG、Mayer Laboratories, Inc、The Female Health Company、Cooper Surgical, Inc、Allergan plc、Cipla Limited、Merck & Co. Inc
・メーカー別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年:避妊薬(経口避妊薬、避妊注射剤、局所避妊薬)、避妊具(男性用避妊具、女性用避妊具)
・用途別分析2016年-2026年:女性用、男性用
・避妊薬・避妊具の北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ
・避妊薬・避妊具のヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア
・避妊薬・避妊具のアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア
・避妊薬・避妊具の南米市場規模2016年-2026年:ブラジル、アルゼンチン
・避妊薬・避妊具の中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
【レポートの概要】

The Contraceptives Drugs and Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Contraceptives Drugs and Devices size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Contraceptives Drugs and Devices market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Contraceptives Drugs and Devices market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Contraceptive Drugs (Oral Contraceptive Pills, Contraceptive Injectables, Topical Contraceptives)
Contraceptive Devices (Male Contraceptive Devices, Female Contraceptive Devices)

Market segment by Application can be divided into
Female
Male

The key market players for global Contraceptives Drugs and Devices market are listed below:
Teva Pharmaceutical Industries Ltd
Church & Dwight Co. Inc
Reckitt Benckiser Plc
Pfizer, Inc
Bayer AG
Mayer Laboratories, Inc
The Female Health Company
Cooper Surgical, Inc
Allergan plc
Cipla Limited
Merck & Co. Inc

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

【レポートの目次】

1 Market Overview
1.1 Contraceptives Drugs and Devices Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Contraceptives Drugs and Devices Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Contraceptive Drugs (Oral Contraceptive Pills, Contraceptive Injectables, Topical Contraceptives)
1.2.3 Contraceptive Devices (Male Contraceptive Devices, Female Contraceptive Devices)
1.3 Market Analysis by Application
1.3.1 Overview: Global Contraceptives Drugs and Devices Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Female
1.3.3 Male
1.4 Global Contraceptives Drugs and Devices Market Size & Forecast
1.4.1 Global Contraceptives Drugs and Devices Sales in Value (2016-2026))
1.4.2 Global Contraceptives Drugs and Devices Sales in Volume (2016-2026)
1.4.3 Global Contraceptives Drugs and Devices Price by Type (2016-2026) & (USD/Unit)
1.5 Global Contraceptives Drugs and Devices Production Capacity Analysis
1.5.1 Global Contraceptives Drugs and Devices Total Production Capacity (2016-2026)
1.5.2 Global Contraceptives Drugs and Devices Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Contraceptives Drugs and Devices Market Drivers
1.6.2 Contraceptives Drugs and Devices Market Restraints
1.6.3 Contraceptives Drugs and Devices Trends Analysis
2 Manufacturers Profiles
2.1 Teva Pharmaceutical Industries Ltd
2.1.1 Teva Pharmaceutical Industries Ltd Details
2.1.2 Teva Pharmaceutical Industries Ltd Major Business
2.1.3 Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices Product and Services
2.1.4 Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Church & Dwight Co. Inc
2.2.1 Church & Dwight Co. Inc Details
2.2.2 Church & Dwight Co. Inc Major Business
2.2.3 Church & Dwight Co. Inc Contraceptives Drugs and Devices Product and Services
2.2.4 Church & Dwight Co. Inc Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Reckitt Benckiser Plc
2.3.1 Reckitt Benckiser Plc Details
2.3.2 Reckitt Benckiser Plc Major Business
2.3.3 Reckitt Benckiser Plc Contraceptives Drugs and Devices Product and Services
2.3.4 Reckitt Benckiser Plc Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Pfizer, Inc
2.4.1 Pfizer, Inc Details
2.4.2 Pfizer, Inc Major Business
2.4.3 Pfizer, Inc Contraceptives Drugs and Devices Product and Services
2.4.4 Pfizer, Inc Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Bayer AG
2.5.1 Bayer AG Details
2.5.2 Bayer AG Major Business
2.5.3 Bayer AG Contraceptives Drugs and Devices Product and Services
2.5.4 Bayer AG Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Mayer Laboratories, Inc
2.6.1 Mayer Laboratories, Inc Details
2.6.2 Mayer Laboratories, Inc Major Business
2.6.3 Mayer Laboratories, Inc Contraceptives Drugs and Devices Product and Services
2.6.4 Mayer Laboratories, Inc Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 The Female Health Company
2.7.1 The Female Health Company Details
2.7.2 The Female Health Company Major Business
2.7.3 The Female Health Company Contraceptives Drugs and Devices Product and Services
2.7.4 The Female Health Company Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Cooper Surgical, Inc
2.8.1 Cooper Surgical, Inc Details
2.8.2 Cooper Surgical, Inc Major Business
2.8.3 Cooper Surgical, Inc Contraceptives Drugs and Devices Product and Services
2.8.4 Cooper Surgical, Inc Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Allergan plc
2.9.1 Allergan plc Details
2.9.2 Allergan plc Major Business
2.9.3 Allergan plc Contraceptives Drugs and Devices Product and Services
2.9.4 Allergan plc Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Cipla Limited
2.10.1 Cipla Limited Details
2.10.2 Cipla Limited Major Business
2.10.3 Cipla Limited Contraceptives Drugs and Devices Product and Services
2.10.4 Cipla Limited Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 Merck & Co. Inc
2.11.1 Merck & Co. Inc Details
2.11.2 Merck & Co. Inc Major Business
2.11.3 Merck & Co. Inc Contraceptives Drugs and Devices Product and Services
2.11.4 Merck & Co. Inc Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Contraceptives Drugs and Devices Sales by Manufacturer
3.1 Global Contraceptives Drugs and Devices Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Contraceptives Drugs and Devices Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Contraceptives Drugs and Devices
3.4 Market Concentration Rate
3.4.1 Top 3 Contraceptives Drugs and Devices Manufacturer Market Share
3.4.2 Top 6 Contraceptives Drugs and Devices Manufacturer Market Share
3.5 Global Contraceptives Drugs and Devices Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Contraceptives Drugs and Devices Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Contraceptives Drugs and Devices Market Size by Region
4.1.1 Global Contraceptives Drugs and Devices Sales in Volume by Region (2016-2026)
4.1.2 Global Contraceptives Drugs and Devices Revenue by Region (2016-2026)
4.2 North America Contraceptives Drugs and Devices Revenue (2016-2026)
4.3 Europe Contraceptives Drugs and Devices Revenue (2016-2026)
4.4 Asia-Pacific Contraceptives Drugs and Devices Revenue (2016-2026)
4.5 South America Contraceptives Drugs and Devices Revenue (2016-2026)
4.6 Middle East and Africa Contraceptives Drugs and Devices Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Contraceptives Drugs and Devices Sales in Volume by Type (2016-2026)
5.2 Global Contraceptives Drugs and Devices Revenue by Type (2016-2026)
5.3 Global Contraceptives Drugs and Devices Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Contraceptives Drugs and Devices Sales in Volume by Application (2016-2026)
6.2 Global Contraceptives Drugs and Devices Revenue by Application (2016-2026)
6.3 Global Contraceptives Drugs and Devices Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Contraceptives Drugs and Devices Sales by Type (2016-2026)
7.2 North America Contraceptives Drugs and Devices Sales by Application (2016-2026)
7.3 North America Contraceptives Drugs and Devices Market Size by Country
7.3.1 North America Contraceptives Drugs and Devices Sales in Volume by Country (2016-2026)
7.3.2 North America Contraceptives Drugs and Devices Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Contraceptives Drugs and Devices Sales by Type (2016-2026)
8.2 Europe Contraceptives Drugs and Devices Sales by Application (2016-2026)
8.3 Europe Contraceptives Drugs and Devices Market Size by Country
8.3.1 Europe Contraceptives Drugs and Devices Sales in Volume by Country (2016-2026)
8.3.2 Europe Contraceptives Drugs and Devices Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Contraceptives Drugs and Devices Sales by Type (2016-2026)
9.2 Asia-Pacific Contraceptives Drugs and Devices Sales by Application (2016-2026)
9.3 Asia-Pacific Contraceptives Drugs and Devices Market Size by Region
9.3.1 Asia-Pacific Contraceptives Drugs and Devices Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Contraceptives Drugs and Devices Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Contraceptives Drugs and Devices Sales by Type (2016-2026)
10.2 South America Contraceptives Drugs and Devices Sales by Application (2016-2026)
10.3 South America Contraceptives Drugs and Devices Market Size by Country
10.3.1 South America Contraceptives Drugs and Devices Sales in Volume by Country (2016-2026)
10.3.2 South America Contraceptives Drugs and Devices Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Contraceptives Drugs and Devices Sales by Type (2016-2026)
11.2 Middle East & Africa Contraceptives Drugs and Devices Sales by Application (2016-2026)
11.3 Middle East & Africa Contraceptives Drugs and Devices Market Size by Country
11.3.1 Middle East & Africa Contraceptives Drugs and Devices Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Contraceptives Drugs and Devices Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Contraceptives Drugs and Devices Typical Distributors
12.3 Contraceptives Drugs and Devices Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Contraceptives Drugs and Devices Revenue by Type, (USD Million), 2021-2026
Table 2. Global Contraceptives Drugs and Devices Revenue by Application, (USD Million), 2021-2026
Table 3. Teva Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 4. Teva Pharmaceutical Industries Ltd Major Business
Table 5. Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices Product and Services
Table 6. Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Church & Dwight Co. Inc Basic Information, Manufacturing Base and Competitors
Table 8. Church & Dwight Co. Inc Major Business
Table 9. Church & Dwight Co. Inc Contraceptives Drugs and Devices Product and Services
Table 10. Church & Dwight Co. Inc Contraceptives Drugs and Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Reckitt Benckiser Plc Basic Information, Manufacturing Base and Competitors
Table 12. Reckitt Benckiser Plc Major Business
Table 13. Reckitt Benckiser Plc Contraceptives Drugs and Devices Product and Services
Table 14. Reckitt Benckiser Plc Contraceptives Drugs and Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Pfizer, Inc Basic Information, Manufacturing Base and Competitors
Table 16. Pfizer, Inc Major Business
Table 17. Pfizer, Inc Contraceptives Drugs and Devices Product and Services
Table 18. Pfizer, Inc Contraceptives Drugs and Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 20. Bayer AG Major Business
Table 21. Bayer AG Contraceptives Drugs and Devices Product and Services
Table 22. Bayer AG Contraceptives Drugs and Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Mayer Laboratories, Inc Basic Information, Manufacturing Base and Competitors
Table 24. Mayer Laboratories, Inc Major Business
Table 25. Mayer Laboratories, Inc Contraceptives Drugs and Devices Product and Services
Table 26. Mayer Laboratories, Inc Contraceptives Drugs and Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. The Female Health Company Basic Information, Manufacturing Base and Competitors
Table 28. The Female Health Company Major Business
Table 29. The Female Health Company Contraceptives Drugs and Devices Product and Services
Table 30. The Female Health Company Contraceptives Drugs and Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Cooper Surgical, Inc Basic Information, Manufacturing Base and Competitors
Table 32. Cooper Surgical, Inc Major Business
Table 33. Cooper Surgical, Inc Contraceptives Drugs and Devices Product and Services
Table 34. Cooper Surgical, Inc Contraceptives Drugs and Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Allergan plc Basic Information, Manufacturing Base and Competitors
Table 36. Allergan plc Major Business
Table 37. Allergan plc Contraceptives Drugs and Devices Product and Services
Table 38. Allergan plc Contraceptives Drugs and Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Cipla Limited Basic Information, Manufacturing Base and Competitors
Table 40. Cipla Limited Major Business
Table 41. Cipla Limited Contraceptives Drugs and Devices Product and Services
Table 42. Cipla Limited Contraceptives Drugs and Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Merck & Co. Inc Basic Information, Manufacturing Base and Competitors
Table 44. Merck & Co. Inc Major Business
Table 45. Merck & Co. Inc Contraceptives Drugs and Devices Product and Services
Table 46. Merck & Co. Inc Contraceptives Drugs and Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Global Contraceptives Drugs and Devices Sales by Manufacturer (2019-2021e) & (K Units)
Table 48. Global Contraceptives Drugs and Devices Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 49. Market Position of Manufacturers in Contraceptives Drugs and Devices, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 50. Global Contraceptives Drugs and Devices Production Capacity by Company, (K Units): 2020 VS 2021
Table 51. Head Office and Contraceptives Drugs and Devices Production Site of Key Manufacturer
Table 52. Global Contraceptives Drugs and Devices Sales by Region (2016-2021e) & (K Units)
Table 53. Global Contraceptives Drugs and Devices Sales by Region (2021-2026) & (K Units)
Table 54. Global Contraceptives Drugs and Devices Revenue by Region (2016-2021e) & (USD Million)
Table 55. Global Contraceptives Drugs and Devices Revenue by Region (2021-2026) & (USD Million)
Table 56. Global Contraceptives Drugs and Devices Sales by Type (2016-2021e) & (K Units)
Table 57. Global Contraceptives Drugs and Devices Sales by Type (2021-2026) & (K Units)
Table 58. Global Contraceptives Drugs and Devices Revenue by Type (2016-2021e) & (USD Million)
Table 59. Global Contraceptives Drugs and Devices Revenue by Type (2021-2026) & (USD Million)
Table 60. Global Contraceptives Drugs and Devices Price by Type (2016-2021e) & (USD/Unit)
Table 61. Global Contraceptives Drugs and Devices Price by Type (2021-2026) & (USD/Unit)
Table 62. Global Contraceptives Drugs and Devices Sales by Application (2016-2021e) & (K Units)
Table 63. Global Contraceptives Drugs and Devices Sales by Application (2021-2026) & (K Units)
Table 64. Global Contraceptives Drugs and Devices Revenue by Application (2016-2021e) & (USD Million)
Table 65. Global Contraceptives Drugs and Devices Revenue by Application (2021-2026) & (USD Million)
Table 66. Global Contraceptives Drugs and Devices Price by Application (2016-2021e) & (USD/Unit)
Table 67. Global Contraceptives Drugs and Devices Price by Application (2021-2026) & (USD/Unit)
Table 68. North America Contraceptives Drugs and Devices Sales by Country (2016-2021e) & (K Units)
Table 69. North America Contraceptives Drugs and Devices Sales by Country (2021-2026) & (K Units)
Table 70. North America Contraceptives Drugs and Devices Revenue by Country (2016-2021e) & (USD Million)
Table 71. North America Contraceptives Drugs and Devices Revenue by Country (2021-2026) & (USD Million)
Table 72. North America Contraceptives Drugs and Devices Sales by Type (2016-2021e) & (K Units)
Table 73. North America Contraceptives Drugs and Devices Sales by Type (2021-2026) & (K Units)
Table 74. North America Contraceptives Drugs and Devices Sales by Application (2016-2021e) & (K Units)
Table 75. North America Contraceptives Drugs and Devices Sales by Application (2021-2026) & (K Units)
Table 76. Europe Contraceptives Drugs and Devices Sales by Country (2016-2021e) & (K Units)
Table 77. Europe Contraceptives Drugs and Devices Sales by Country (2021-2026) & (K Units)
Table 78. Europe Contraceptives Drugs and Devices Revenue by Country (2016-2021e) & (USD Million)
Table 79. Europe Contraceptives Drugs and Devices Revenue by Country (2021-2026) & (USD Million)
Table 80. Europe Contraceptives Drugs and Devices Sales by Type (2016-2021e) & (K Units)
Table 81. Europe Contraceptives Drugs and Devices Sales by Type (2021-2026) & (K Units)
Table 82. Europe Contraceptives Drugs and Devices Sales by Application (2016-2021e) & (K Units)
Table 83. Europe Contraceptives Drugs and Devices Sales by Application (2021-2026) & (K Units)
Table 84. Asia-Pacific Contraceptives Drugs and Devices Sales by Region (2016-2021e) & (K Units)
Table 85. Asia-Pacific Contraceptives Drugs and Devices Sales by Region (2021-2026) & (K Units)
Table 86. Asia-Pacific Contraceptives Drugs and Devices Revenue by Region (2016-2021e) & (USD Million)
Table 87. Asia-Pacific Contraceptives Drugs and Devices Revenue by Region (2021-2026) & (USD Million)
Table 88. Asia-Pacific Contraceptives Drugs and Devices Sales by Type (2016-2021e) & (K Units)
Table 89. Asia-Pacific Contraceptives Drugs and Devices Sales by Type (2021-2026) & (K Units)
Table 90. Asia-Pacific Contraceptives Drugs and Devices Sales by Application (2016-2021e) & (K Units)
Table 91. Asia-Pacific Contraceptives Drugs and Devices Sales by Application (2021-2026) & (K Units)
Table 92. South America Contraceptives Drugs and Devices Sales by Country (2016-2021e) & (K Units)
Table 93. South America Contraceptives Drugs and Devices Sales by Country (2021-2026) & (K Units)
Table 94. South America Contraceptives Drugs and Devices Revenue by Country (2016-2021e) & (USD Million)
Table 95. South America Contraceptives Drugs and Devices Revenue by Country (2021-2026) & (USD Million)
Table 96. South America Contraceptives Drugs and Devices Sales by Type (2016-2021e) & (K Units)
Table 97. South America Contraceptives Drugs and Devices Sales by Type (2021-2026) & (K Units)
Table 98. South America Contraceptives Drugs and Devices Sales by Application (2016-2021e) & (K Units)
Table 99. South America Contraceptives Drugs and Devices Sales by Application (2021-2026) & (K Units)
Table 100. Middle East & Africa Contraceptives Drugs and Devices Sales by Country (2016-2021e) & (K Units)
Table 101. Middle East & Africa Contraceptives Drugs and Devices Sales by Country (2021-2026) & (K Units)
Table 102. Middle East & Africa Contraceptives Drugs and Devices Revenue by Country (2016-2021e) & (USD Million)
Table 103. Middle East & Africa Contraceptives Drugs and Devices Revenue by Country (2021-2026) & (USD Million)
Table 104. Middle East & Africa Contraceptives Drugs and Devices Sales by Type (2016-2021e) & (K Units)
Table 105. Middle East & Africa Contraceptives Drugs and Devices Sales by Type (2021-2026) & (K Units)
Table 106. Middle East & Africa Contraceptives Drugs and Devices Sales by Application (2016-2021e) & (K Units)
Table 107. Middle East & Africa Contraceptives Drugs and Devices Sales by Application (2021-2026) & (K Units)
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Contraceptives Drugs and Devices Typical Distributors
Table 111. Contraceptives Drugs and Devices Typical Customers
List of Figures
Figure 1. Contraceptives Drugs and Devices Picture
Figure 2. Global Contraceptives Drugs and Devices Sales Market Share by Type in 2020
Figure 3. Contraceptive Drugs (Oral Contraceptive Pills, Contraceptive Injectables, Topical Contraceptives)
Figure 4. Contraceptive Devices (Male Contraceptive Devices, Female Contraceptive Devices)
Figure 5. Global Contraceptives Drugs and Devices Sales Market Share by Application in 2020
Figure 6. Female
Figure 7. Male
Figure 8. Global Contraceptives Drugs and Devices Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 9. Global Contraceptives Drugs and Devices Market Size and Forecast (2016-2026) & (USD Million)
Figure 10. United States Contraceptives Drugs and Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 11. Canada Contraceptives Drugs and Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Mexico Contraceptives Drugs and Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Germany Contraceptives Drugs and Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. France Contraceptives Drugs and Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. United Kingdom Contraceptives Drugs and Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Russia Contraceptives Drugs and Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Italy Contraceptives Drugs and Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. China Contraceptives Drugs and Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Japan Contraceptives Drugs and Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Korea Contraceptives Drugs and Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. India Contraceptives Drugs and Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Southeast Asia Contraceptives Drugs and Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Australia Contraceptives Drugs and Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Brazil Contraceptives Drugs and Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Egypt Contraceptives Drugs and Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Saudi Arabia Contraceptives Drugs and Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. South Africa Contraceptives Drugs and Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Turkey Contraceptives Drugs and Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Global Contraceptives Drugs and Devices Sales (2016-2026) & (K Units)
Figure 30. Global Contraceptives Drugs and Devices Production Capacity (2016-2026) & (K Units)
Figure 31. Global Contraceptives Drugs and Devices Production Capacity by Geographic Region: 2020 VS 2021
Figure 32. Contraceptives Drugs and Devices Market Drivers
Figure 33. Contraceptives Drugs and Devices Market Restraints
Figure 34. Contraceptives Drugs and Devices Market Trends
Figure 35. Global Contraceptives Drugs and Devices Sales Market Share by Manufacturer in 2020
Figure 36. Global Contraceptives Drugs and Devices Revenue Market Share by Manufacturer in 2020
Figure 37. Contraceptives Drugs and Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 38. Top 3 Contraceptives Drugs and Devices Manufacturer (Revenue) Market Share in 2020
Figure 39. Top 6 Contraceptives Drugs and Devices Manufacturer (Revenue) Market Share in 2020
Figure 40. Global Contraceptives Drugs and Devices Sales Market Share by Region (2016-2026)
Figure 41. Global Contraceptives Drugs and Devices Revenue Market Share by Region (2016-2026)
Figure 42. North America Contraceptives Drugs and Devices Revenue (2016-2026) & (USD Million)
Figure 43. Europe Contraceptives Drugs and Devices Revenue (2016-2026) & (USD Million)
Figure 44. Asia-Pacific Contraceptives Drugs and Devices Revenue (2016-2026) & (USD Million)
Figure 45. South America Contraceptives Drugs and Devices Revenue (2016-2026) & (USD Million)
Figure 46. Middle East & Africa Contraceptives Drugs and Devices Revenue (2016-2026) & (USD Million)
Figure 47. Global Contraceptives Drugs and Devices Sales Market Share by Type (2016-2026)
Figure 48. Global Contraceptives Drugs and Devices Revenue Market Share by Type (2016-2026)
Figure 49. Global Contraceptives Drugs and Devices Price by Type (2016-2026) & (USD/Unit)
Figure 50. Global Contraceptives Drugs and Devices Sales Market Share by Application (2016-2026)
Figure 51. Global Contraceptives Drugs and Devices Revenue Market Share by Application (2016-2026)
Figure 52. Global Contraceptives Drugs and Devices Price by Application (2016-2026) & (USD/Unit)
Figure 53. North America Contraceptives Drugs and Devices Sales Market Share by Country (2016-2026)
Figure 54. North America Contraceptives Drugs and Devices Revenue Market Share by Country (2016-2026)
Figure 55. North America Contraceptives Drugs and Devices Sales Market Share by Type (2016-2026)
Figure 56. North America Contraceptives Drugs and Devices Sales Market Share by Application (2016-2026)
Figure 57. Europe Contraceptives Drugs and Devices Sales Market Share by Country (2016-2026)
Figure 58. Europe Contraceptives Drugs and Devices Revenue Market Share by Country (2016-2026)
Figure 59. Europe Contraceptives Drugs and Devices Sales Market Share by Type (2016-2026)
Figure 60. Europe Contraceptives Drugs and Devices Sales Market Share by Application (2016-2026)
Figure 61. Asia-Pacific Contraceptives Drugs and Devices Sales Market Share by Region (2016-2026)
Figure 62. Asia-Pacific Contraceptives Drugs and Devices Revenue Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Contraceptives Drugs and Devices Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Contraceptives Drugs and Devices Sales Market Share by Application (2016-2026)
Figure 65. South America Contraceptives Drugs and Devices Sales Market Share by Country (2016-2026)
Figure 66. South America Contraceptives Drugs and Devices Revenue Market Share by Country (2016-2026)
Figure 67. South America Contraceptives Drugs and Devices Sales Market Share by Type (2016-2026)
Figure 68. South America Contraceptives Drugs and Devices Sales Market Share by Application (2016-2026)
Figure 69. Middle East & Africa Contraceptives Drugs and Devices Sales Market Share by Country (2016-2026)
Figure 70. Middle East & Africa Contraceptives Drugs and Devices Revenue Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Contraceptives Drugs and Devices Sales Market Share by Type (2016-2026)
Figure 72. Middle East & Africa Contraceptives Drugs and Devices Sales Market Share by Application (2016-2026)
Figure 73. Sales Channel: Direct Channel vs Indirect Channel
Figure 74. Methodology
Figure 75. Research Process and Data Source


【掲載企業】

Teva Pharmaceutical Industries Ltd、Church & Dwight Co. Inc、Reckitt Benckiser Plc、Pfizer, Inc、Bayer AG、Mayer Laboratories, Inc、The Female Health Company、Cooper Surgical, Inc、Allergan plc、Cipla Limited、Merck & Co. Inc

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の避妊薬・避妊具市場2021:メーカー別・地域別・種類別・用途別市場予測(~2026)(Global Contraceptives Drugs and Devices Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026)]についてメールでお問い合わせはこちらでお願いします。